PACB — Pacific Biosciences of California · rev $76.2M

Pacific Biosciences of California (PACB) is a medical devices company listed on US.

Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.

Use this PACB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PACB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PACB SEC filings page. Lician reads the product cache first so this HTML stays unique to Pacific Biosciences of California even when a live quote feed is slow.

Pacific Biosciences of California latest statements (FY2025)

Latest cached year on this hub. Full PACB income, balance, and cash tables.

  • Revenue$160.0M
  • Net Income-$546.4M
  • Total Assets$784.1M
  • Total Debt$0
  • Free Cash Flow-$113.9M

PACB recent filings